25 results
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
to obligations or liabilities incurred, in the Ordinary Course, in respect of workers compensation claims, health, disability or other employee … disability or other defense (other than the defense that the Guaranteed Obligations shall have been fully and finally performed and indefeasibly paid
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
, in the Ordinary Course, including in
-87-
4882-5123-79004861-6868-3896 v.123
respect of workers compensation claims, health, disability or other employee … by reason of any disability or other defense (other than the defense that the Guaranteed Obligations shall have been fully and finally performed
10-K/A
2022 FY
EX-3.2
IMPLQ
Impel Pharmaceuticals Inc
31 Mar 23
Annual report (amended)
4:21pm
the powers of the Chief Executive Officer or President in the event of the Chief Executive Officer’s or President’s absence or disability.
Section 4.9
10-K
h21 6fvvwrn
29 Mar 22
Annual report
5:09pm
8-K
EX-99.1
pvx6k961 i2v5j8
15 Nov 21
Impel NeuroPharma Announces THIRD Quarter 2021 Financial Results and Provides CORPORATE Update
8:04am
424B4
o366eix8cujyow2
10 Sep 21
Prospectus supplement with pricing info
4:01pm
DRS
5tj490wylwi 8md
25 Aug 21
Draft registration statement
12:00am
10-Q
EX-3.2
x5nmufyahfd9mh4tq
7 Jun 21
Quarterly report
7:17am
424B1
h0srot0 0vmuq8ye
23 Apr 21
Prospectus with pricing info
4:01pm
S-1
EX-10.9
xwgc f45p943
2 Apr 21
IPO registration
3:04pm
S-1
EX-10.10
slgd yie7g
2 Apr 21
IPO registration
3:04pm